MedTrace Logo

Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

NCT06420505 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2024-06-06

No results posted yet for this study

Summary

The rationale for this observatory is to evaluate clinical outcomes and collect data of the Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with follow-up at 12 months. All medications and procedures to be used/ performed in this observatory are commonly used/performed for clinical indications as part of standard of care and have well-defined safety profiles.

Conditions

  • Artery Coronary Stenosis

Interventions

DEVICE

Percutaneous Coronary Intervention

The Vivo ISAR is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease.

Sponsors & Collaborators

  • EVAMED

    collaborator OTHER

  • Translumina GmbH

    lead INDUSTRY

Principal Investigators

  • Thibault Lhermusier, Pr · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-29
Primary Completion
2026-11-29
Completion
2027-01-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06420505 on ClinicalTrials.gov